Erectile Dysfunction Drugs Global Market 2017 with a CAGR of 6.5% : Key Players – Pfizer Inc., Bayer AG, Eli Lily & Co., and More

Executive Summary:
Market Research Future published new report, titled “Erectile Dysfunction Drugs Market -Research Report: Global Forecast to 2023”.

Market Synopsis of Global Erectile Dysfunction Drugs Market

GET SAMPLE REPORT @ http://bit.ly/2xZwN0n

Market Scenario:
Inability to keep firm erection firm enough during sexual intercourse in known as erectile dysfunction. It is also known as impotence. It is a common medical disorder primarily affecting men older than 40 years of age. Stress and mental health concerns may worsen the problem of erectile dysfunction. Physical and psychological issues may also cause erectile dysfunction. The market of erectile dysfunction drugs is driven by the number of drugs available in the market and increasing number of men suffering from this disorder available. There is also an increase in the competition among the major market players. Patent expiry of number of blockbuster drugs, availability of counterfeit drugs and increasing manufactures of generic drugs in the market may result in the decline of erectile dysfunction drugs market. Global market of erectile dysfunction drugs is expected to reach USD 2.95 billion in 2023 from USD 1.65 billion in 2016 with a CAGR of approximately 6.5% during the forecast period 2017-2023.

Market Segments:
Global Erectile dysfunction drugs market has been segmented on the basis of product which includes Viagra, Cialis, Levitra, Stendra, Zydena and other drugs and on the basis of end users the market is segmented into Hospitals, clinics, pharmaceutical companies and others.

Key Players:
Pfizer Inc. (U.S), Bayer AG (Germany), Eli Lily & Co. (U.S), Dong–A Pharmaceutical Co. Ltd.(South Korea), Apricus Biosciences Inc.(U.S), S.K. Chemicals Co. Ltd. (South Korea), Apricus Biosciences Inc. (U.S).

GET FULL REPORT @ http://bit.ly/2y0Byan

Market Assessment:
The report for Erectile Dysfunction Market of Market Research Future comprises of extensive primary research along with detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value & volume, technological advancement, macro economical, and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Regional Analysis:
Globally, erectile dysfunction drugs market consists of four regions Americas, Europe, Asia-Pacific and Middle East and Africa. North America is the largest market. Europe is the second largest market. Asia Pacific shows fastest growth in this market. The market shows steady growth in Middle East and Africa.

Study Objectives:
Main objective of this research is to provide information about erectile dysfunction drugs market, products and end users.
·To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the erectile dysfunction drugs market.
·To provide insights about factors affecting the market growth.
·To analyze the erectile dysfunction drugs market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
·To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific and Middle East and Africa.
·To provide country level analysis of the market with respect to the current market size and future prospective.
·To provide country level analysis of the market for segments by products, by end users and its sub-segments.
·To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
·To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global erectile dysfunction drugs market.

Intended Audience:
·Erectile Dysfunction Drugs manufacturers
·Erectile Dysfunction Drugs suppliers
·Contract Research Organizations (CROs)
·Research and Development (R&D) Companies
·Academic Medical Institutes and Universities

BUY-NOW REPORT @ http://bit.ly/2yohKi8

Table of Contents:
1. Report Prologue

2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation

3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimatio
3.5 Forecast Model

4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Threats
4.5 Macroeconomic Indicators

5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
5.6 Merger And Acquisition Landscape
5.7 Up-Coming Trends In Erectile Dysfunction Drugs Market
5.7.1 Market Trends
5.7.2 Technological Trends
...
10.1 Pfizer Inc.
10.1.1 Overview
10.1.2 Product/Business Segment Overview
10.1.3 Financial Updates
10.1.4 Key Developments

10.2 Bayer AG
10.2.1 Overview
10.2.2 Product/Business Segment Overview
10.2.3 Financial Updates
10.2.4 Key Developments

10.3 Eli Lily & Co.
10.3.1 Overview
10.3.2 Product/Business Segment Overview
10.3.3 Financial Updates
10.3.4 Key Developments

10.4 Dong – A Pharmaceutical Co. Ltd.
10.4.1 Overview
10.4.2 Product/Business Segment Overview
10.4.3 Financial Updates
10.4.4 Key Development

10.5 Apricus Biosciences Inc.
10.5.1 Overview
10.5.2 Product/Business Segment Overview
10.5.3 Financial Updates
10.5.4 Key Developments

10.6 S.K. Chemicals Co. Ltd.
10.6.1 Overview
10.6.2 Product/Business Segment Overview
10.6.3 Financial Updates
10.6.4 Key Developments

10.7 Apricus Biosciences Inc.
10.7.1 Overview
10.7.2 Product/Business Segment Overview
10.7.3 Financial Updates
10.7.4 Key Developments

10.8 Others

...CONTINUED

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: salesteam@marketresearchfuture.com
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune – 411028
Maharashtra, India

This release was published on openPR.